BACKGROUND AND PURPOSE: Although the treatment window for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) has been extended in recent years, it has been proven that recanalizing treatment must be administered as soon as possible. We present a new standard operating procedure (SOP) to reduce in-house delay, standardize periinterventional management and improve patient safety during MT. METHODS: KEep Evaluating Protocol Simplification In Managing Periinterventional Light Sedation for Endovascular Stroke Treatment (KEEP SIMPLEST) was a prospective, single-center observational study aimed to compare aspects of periinterventional management in AIS patients treated according to our new SOP using a combination of esketamine and propofol with patients having been randomized into conscious sedation (CS) in the Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial. Primary outcome was early neurological improvement at 24h using the National Institutes of Health Stroke Scale, and secondary outcomes were door-to-recanalization, recanalization grade, conversion rate and modified Rankin Scale (mRS) at 3 months. RESULTS: Door-to-recanalization time (128.6 ± 69.47 min vs. 156.8 ± 75.91 min; p = 0.02), mean duration of MT (92.01 ± 52 min vs. 131.9 ± 64.03 min; p < 0.001), door-to-first angiographic image (51.61 ± 31.7 min vs. 64.23 ± 21.53 min; p = 0.003) and computed tomography-to-first angiographic image time (31.61 ± 20.6 min vs. 44.61 ± 19.3 min; p < 0.001) were significantly shorter in the group treated under the new SOP. There were no differences in early neurological improvement, mRS at 3 months or other secondary outcomes between the groups. Conversion rates of CS to general anesthesia were similar in both groups. CONCLUSION: An SOP using a novel sedation regimen and optimization of equipment and procedures directed at a leaner, more integrative and compact periinterventional management can reduce in-house treatment delays significantly in stroke patients receiving thrombectomy in light sedation and demonstrated the safety and feasibility of our improved approach.
BACKGROUND AND PURPOSE: Although the treatment window for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) has been extended in recent years, it has been proven that recanalizing treatment must be administered as soon as possible. We present a new standard operating procedure (SOP) to reduce in-house delay, standardize periinterventional management and improve patient safety during MT. METHODS: KEep Evaluating Protocol Simplification In Managing Periinterventional Light Sedation for Endovascular Stroke Treatment (KEEP SIMPLEST) was a prospective, single-center observational study aimed to compare aspects of periinterventional management in AIS patients treated according to our new SOP using a combination of esketamine and propofol with patients having been randomized into conscious sedation (CS) in the Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial. Primary outcome was early neurological improvement at 24h using the National Institutes of Health Stroke Scale, and secondary outcomes were door-to-recanalization, recanalization grade, conversion rate and modified Rankin Scale (mRS) at 3 months. RESULTS: Door-to-recanalization time (128.6 ± 69.47 min vs. 156.8 ± 75.91 min; p = 0.02), mean duration of MT (92.01 ± 52 min vs. 131.9 ± 64.03 min; p < 0.001), door-to-first angiographic image (51.61 ± 31.7 min vs. 64.23 ± 21.53 min; p = 0.003) and computed tomography-to-first angiographic image time (31.61 ± 20.6 min vs. 44.61 ± 19.3 min; p < 0.001) were significantly shorter in the group treated under the new SOP. There were no differences in early neurological improvement, mRS at 3 months or other secondary outcomes between the groups. Conversion rates of CS to general anesthesia were similar in both groups. CONCLUSION: An SOP using a novel sedation regimen and optimization of equipment and procedures directed at a leaner, more integrative and compact periinterventional management can reduce in-house treatment delays significantly in stroke patients receiving thrombectomy in light sedation and demonstrated the safety and feasibility of our improved approach.
Authors: Marc Ribo; Sandra Boned; Marta Rubiera; Alejandro Tomasello; Pilar Coscojuela; David Hernández; Jorge Pagola; Jesús Juega; Noelia Rodriguez; Marian Muchada; David Rodriguez-Luna; Carlos A Molina Journal: J Neurointerv Surg Date: 2017-04-26 Impact factor: 5.836
Authors: M Mehdiratta; A R Woolfenden; K M Chapman; Dean C Johnston; M Schulzer; J Beckman; P A Teal Journal: Can J Neurol Sci Date: 2006-05 Impact factor: 2.104
Authors: Benjamin Y Q Tan; Nicholas J H Ngiam; Sibi Sunny; Wan Yee Kong; Howen Tam; Tiong Beng Sim; Benjamin S H Leong; Chandra Bhartendu; Prakash R Paliwal; Raymond C S Seet; Bernard P L Chan; Hock Luen Teoh; Vijay K Sharma; Leonard L L Yeo Journal: J Stroke Cerebrovasc Dis Date: 2018-02-13 Impact factor: 2.136
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: Hongjin Wang; Arthur Thevathasan; Richard Dowling; Steven Bush; Peter Mitchell; Bernard Yan Journal: J Stroke Cerebrovasc Dis Date: 2017-06-01 Impact factor: 2.136
Authors: Jeffrey L Saver; Mayank Goyal; Aad van der Lugt; Bijoy K Menon; Charles B L M Majoie; Diederik W Dippel; Bruce C Campbell; Raul G Nogueira; Andrew M Demchuk; Alejandro Tomasello; Pere Cardona; Thomas G Devlin; Donald F Frei; Richard du Mesnil de Rochemont; Olvert A Berkhemer; Tudor G Jovin; Adnan H Siddiqui; Wim H van Zwam; Stephen M Davis; Carlos Castaño; Biggya L Sapkota; Puck S Fransen; Carlos Molina; Robert J van Oostenbrugge; Ángel Chamorro; Hester Lingsma; Frank L Silver; Geoffrey A Donnan; Ashfaq Shuaib; Scott Brown; Bruce Stouch; Peter J Mitchell; Antoni Davalos; Yvo B W E M Roos; Michael D Hill Journal: JAMA Date: 2016-09-27 Impact factor: 56.272
Authors: Maxim J H L Mulder; Ivo G H Jansen; Robert-Jan B Goldhoorn; Esmee Venema; Vicky Chalos; Kars C J Compagne; Bob Roozenbeek; Hester F Lingsma; Wouter J Schonewille; Ido R van den Wijngaard; Jelis Boiten; Jan Albert Vos; Yvo B W Em Roos; Robert J van Oostenbrugge; Wim H van Zwam; Charles B L M Majoie; Aad van der Lugt; Diederik W J Dippel Journal: Circulation Date: 2018-03-26 Impact factor: 29.690
Authors: Brijesh P Mehta; Thabele M Leslie-Mazwi; Ronil V Chandra; Donnie L Bell; Chung-Huan J Sun; Joshua A Hirsch; James D Rabinov; Natalia S Rost; Lee H Schwamm; Joshua N Goldstein; Wilton C Levine; Rishi Gupta; Albert J Yoo Journal: J Am Heart Assoc Date: 2014-11-11 Impact factor: 5.501
Authors: Renato Tosello; Rachel Riera; Giuliano Tosello; Caroline Nb Clezar; Jorge E Amorim; Vladimir Vasconcelos; Benedito B Joao; Ronald Lg Flumignan Journal: Cochrane Database Syst Rev Date: 2022-07-20
Authors: David C Lauzier; Maria M Galardi; Kristin P Guilliams; Manu S Goyal; Catherine Amlie-Lefond; Danial K Hallam; Akash P Kansagra Journal: Stroke Date: 2021-03-11 Impact factor: 7.914
Authors: Loraine Busetto; Johanna Hoffmann; Christina Stang; Hemasse Amiri; Fatih Seker; Jan Purrucker; Peter Arthur Ringleb; Simon Nagel; Martin Bendszus; Wolfgang Wick; Christoph Gumbinger Journal: Int J Integr Care Date: 2022-02-21 Impact factor: 5.120
Authors: Min Chen; Dorothea Kronsteiner; Johannes Pfaff; Simon Schieber; Laura Jäger; Martin Bendszus; Meinhard Kieser; Markus A Möhlenbruch; Peter A Ringleb; Julian Bösel; Silvia Schönenberger Journal: Neurocrit Care Date: 2021-06-17 Impact factor: 3.210